The decline and rise of coronary heart disease: Understanding public health catastrophism

American Journal of Public Health

Volumn 103, Issue 7, 2013, Pages 1207-1218

  Jones, David S ^a,c   Greene, Jeremy A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Science Center 371   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATASTROPHIZING; COMMUNICABLE DISEASE; CORONARY ARTERY DISEASE; HEALTH; HEALTH CARE POLICY; HEALTH SURVEY; HISTORY; HUMAN; MORTALITY; UNITED STATES;

CATASTROPHIZATION; COMMUNICABLE DISEASES; CORONARY DISEASE; HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PUBLIC HEALTH SURVEILLANCE; UNITED STATES; WORLD HEALTH;

MLCS; MLOWN;

EID: 84879010545     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301226     Document Type: Article

References (117)

1. D. S. Jones and J. A. Greene, "The Contributions of Prevention and Treatment to the Decline in Cardiovascular Mortality: Lessons From a Forty-Year Debate," Health Affairs (Millwood) 31, no. 10 (2012): 2250-2258.
2. D. Brown, "Life Expectancy in the US Varies Widely by Region, in Some Places is Decreasing," Washington Post, June 15, 2011, http://www.washingtonpost.com/national/lifeexpectancy-in-the-us-va... on-and-in-someplaces-is-decreasing/2011/06/13/AGdHuZVH-story.html (accessed June 18, 2012)
3. Sabrina Tavernise, "Life Expectancy Shrinks for Less-Educated Whites in U.S.," New York Times, September 20, 2012, http://www.nytimes.com/2012/ 09/21/us/life-expectancyfor-less-educated-whites-in-us-isshrinking.html? hp&pagewanted=print (accessed September 20, 2012).
4. N. O. Borhani and H. H. Hechter, "Recent Changes in Cardiovascular Disease Mortality in California," Public Health Reports 79 (1964): 147-160.
5. R. H. Moser, "Signs of Spring?" JAMA 227, no. 9 (1974): 1049
6. W. J. Walker, "Coronary Mortality: What Is Going On?" JAMA 227, no. 9 (1974): 1045-1046. Walker, a member of JAMA's editorial board, had published widely in cardiology since the 1950s, but this was his first foray into cardiovascular epidemiology. He followed up with a scathing indictment of Congress. He harangued Congress for subsidizing the tobacco industry even as it spent billions of dollars caring for tobacco's victims. Even though Congress knew the exact size of the tobacco subsidy, it underfunded the National Center for Health Statistics and had no up-to-date estimates of tobacco-related mortality.
7. See W. J. Walker, "Government Subsidized Death and Disability, Journal of the American Medical Association 230, no. 11 (1974): 1529-1530.
8. P. Leaverton, "Oral History," interview by Henry Blackburn, February 21, 2002, http://www.epi.umn.edu/cvdepi/interview.asp?id=43 (accessed November 28, 2011).
9. Tavia Gordon and Thomas Thom, "The Recent Decrease in CHD Mortality," Preventive Medicine 4, no. 2 (1975): 115-125, on p. 120.
10. R. J. Havlik and M. Feinleib, eds. Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality (Bethesda, MD: Department of Health, Education, and Welfare, 1979).
11. Jeremiah Stamler, "Lifestyles, Major Risk Factors, Proof and Public Policy," Circulation. 58, no. 1 (1978): 3-19, on p. 15. (Pubitemid 8376653)
12. Why the American Decline in Coronary Heart-Disease?" Lancet 315, no. 8161 (1980): 183-184, on p. 183.
13. R. J. Havlik, "Understanding the Decline in Coronary Heart Disease Mortality," JAMA 247, no. 11 (1982): 1605-1606, on p. 1606. (Pubitemid 12180087)
14. Michael P. Stern, "The Recent Decline in Ischemic Heart Disease Mortality," Annals of Internal Medicine 91, no. 4 (1979): 630-640, on p. 639.
15. H. Blackburn, "'The Decline.' Surveillance and Trends of Coronary Death," (unpublished data, 2012)
16. Leaverton, "Oral History"
17. ARIC Investigators, "The Atherosclerosis Risk in Communities (ARIC) Study: Design and Objectives" American Journal of Epidemiology 129, no. 4 (1989): 687-702. Independent groups undertook similar surveillance programs in Minneapolis and Rochester, MN, and Worcester, MA.
18. Blackburn, "The Decline"
19. S. Bothig, "WHO Monica Project: Objectives and Design," International Journal of Epidemiology 18, suppl 1 (1989): S29-S37 (Pubitemid 19270189)
20. J. Tuomilehto and K. Kuulasmaa, "WHO MONICA Project: Assessing CHD Mortality and Morbidity," International Journal of Epidemiology 18, suppl 1 (1989): S38-S45. (Pubitemid 19270190)
21. Blackburn, "The Decline."
22. W. Harlan, "CHD Trends in the United States: Overview" International Journal of Epidemiology 18, no. 3, suppl 1 (1989): S56-S57. (Pubitemid 19270192)
23. Millicent Higgins and Thomas Thom, "Trends in CHD in the United States," International Journal of Epidemiology 18, suppl 1 (1989): S58-S66. (Pubitemid 19270193)
24. Millicent W. Higgins and Russel V. Luepker, "Preface," International Journal of Epidemiology 18, suppl 1 (1989): S1-S2
25. Wayne D. Rosamond et al. for the ARIC Investigators, "Coronary Heart Disease Trends in Four United States Communities: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996," International Journal of Epidemiology 30 (2001): S17-S22, esp. S21 (Pubitemid 33041207)
26. H. Tunstall-Pedoe et al., "Contribution of Trends in Survival and Coronary-Event Rates to Changes in Coronary Heart Disease Mortality: 10-Year Results from 37 WHO Monica Project Populations: Monitoring Trends and Determinants in Cardiovascular Disease," Lancet 353, no. 9164 (1999): 1547-1557. (Pubitemid 29219203)
27. Tuomilehto, "WHO MONICA Project"
28. Tunstall-Pedoe et al., "Contribution of Trends."
29. Lee Goldman and E. Francis Cook, "The Decline in Ischemic Heart Disease Mortality Rates: An Analysis of the Comparative Effects of Medical Interventions and Changes in Lifestyle," Annals of Internal Medicine 101, no. 6 (1984): 825-836, on p. 832. (Pubitemid 15187377)
30. Simon Capewell, C. E. Morrison, and J. J. McMurray, "Contribution of Modern Cardiovascular Treatment and Risk Factor Changes to the Decline in Coronary Heart Disease Mortality in Scotland Between 1975 and 1994," Heart 81, no. 4 (1999): 380-386, on p. 385. (Pubitemid 29167127)
31. B. Unal, S. Capewell, and J. A. Critchley, "Coronary Heart Disease Policy Models: A Systematic Review" Bio Med Central Public Health. 2006;6:213 [10 pages].
32. Jones and Greene, "The Contributions of Prevention and Treatment."
33. Lewis Carroll, Alice's Adventures in Wonderland (1865; reprint, New York, NY: Macmillan, 1920), p. 34.
34. L. Björck et al., "Increasing Evidence-Based Treatments to Reduce Coronary Heart Disease Mortality in Sweden: Quantifying the Potential Gains," Journal of Internal Medicine 269, no. 4 (2011): 452-467.
35. E. S. Ford and S. Capewell, "Proportion of the Decline in Cardiovascular Mortality Disease Due to Prevention Versus Treatment: Public Health Versus Clinical Care," Annual Review of Public Health 32 (2011): 5-22.
36. Higgins and Thom, "Trends"
37. Blackburn, "The Decline."
38. J. T. Salonen, P. Puska, and H. Mustaniemi, "Changes in Morbidity and Mortality During Comprehensive Community Programme to Control Cardiovascular Diseases During 1972-7 in North Karelia," British Medical Journal 2, no. 6199 (1979): 1178-1183. (Pubitemid 10202039)
39. J. Tuomilehto et al., "Trends and Determinants of Ischaemic Heart Disease Mortality in Finland: With Special Reference to a Possible Levelling Off in the Early 1980s," International Journal of Epidemiology 18, suppl 1 (1989): S109-S117, on pp. 109, 114. (Pubitemid 19270200)
40. Geoffrey Rose, "Causes of the Trends and Variations in CHD Mortality in Different Countries," International Journal of Epidemiology 18, suppl 1 (1989): S174-S179, on p. 176. (Pubitemid 19270211)
41. R. Cooper et al., "Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States: Findings of the National Conference on Cardiovascular Disease Prevention," Circulation 102 (2000): 3137-3147, on p. 3145.
42. A. Wilson and V. Siskind, "Coronary Heart Disease Mortality in Australia: Is Mortality Starting to Increase Among Young Men?" International Journal of Epidemiology 24, no. 4 (1995): 678-684
43. M. Tobias and P. Searle, "Does Geography Explain Ethnic Inequalities in Health in New Zealand? Australia and New Zealand Journal of Public Health 30, no. 5 (2006): 457-460. (Pubitemid 44614453)
44. David S. Ludwig and Cara B. Ebbeling, "Type 2 Diabetes Mellitus in Children: Primary Care and Public Health Considerations," JAMA 286, no. 12 (2001): 1427-1430, on p. 1429. (Pubitemid 33015490)
45. S. J. Olshansky et al., "A Potential Decline in Life Expectancy in the United States in the 21st Century," New England Journal of Medicine 352, no. 11 (2005): 1138-1145, on p. 1139. (Pubitemid 40365358)
46. Karen Wright, "Staying Alive," Discover, November 6, 2003, http://discovermagazine.com/2003/nov/cover/article-print (accessed May 29, 2012)
47. James W. Vaupel, "Biodemography of Human Ageing," Nature 464, no. 7288 (2010): 536-542.
48. Olshansky et al., "A Potential Decline," 1143.
49. E. S. Ford and S. Capewell, "Coronary Heart Disease Mortality Among Young Adults in the US From 1980 Through 2002: Concealed Leveling of Mortality Rates," Journal of the American College of Cardiology 50, no. 22 (2007): 2128-2132, on pp. 2128, 2131. (Pubitemid 350117339)
50. M. O'Flaherty et al., "Coronary Heart Disease Trends in England and Wales From 1984 to 2004: Concealed Levelling of Mortality Rates Among Young Adults," Heart 94, no. 2 (2008): 178-181 (Pubitemid 351211725)
51. M. O'Flaherty et al., "Coronary Heart Disease Mortality Among Young Adults in Scotland in Relation to Social Inequalities: Time Trend Study," British Medical Journal 339 (2009): b2613
52. I. Vaartjes et al., "Coronary Heart Disease Mortality Trends in the Netherlands 1972-2007," Heart 97, no. 7 (2011): 569-573
53. M. O'Flaherty et al., "The Decline in Coronary Heart Disease Mortality Is Slowing in Young Adults (Australia 1976-2006): A Time Trend Analysis, International Journal of Cardiology 158, no. 2 (2012): 193-198.
54. E. S. Ford, et al., "Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000, New England Journal of Medicine 356, no. 23 (2007): 2388-2398. (Pubitemid 46883773)
55. S. Capewell and M. O'Flaherty, "What Explains Declining Coronary Mortality? Lessons and Warnings," Heart 94, no. 9 (2008): 1105-1108.
56. Ford and Capewell, "Coronary Heart Disease Mortality," 2131.
57. "US Adults Are Getting Sicker," FoxNews.com, July 31, 2012, http://www.foxnews.com/health/2012/07/31/us-adults-are-getting-sicker (accessed October 7, 2012)
58. Tavernise, "Life Spans Shrink."
59. V. Shkolnikov, F. Mesle, and J. Vallin, "Health Crisis in Russia. I. Recent Trends in Life Expectancy and Causes of Death from 1970 to 1993," Population: English Selection 8 (1996): 123-154.
60. See also John Lewis Gaddis, We Now Know: Rethinking Cold War History (Oxford, UK: Oxford University Press, 1997).
61. A. D. Deev and R. G. Oganov, "Trends and Determinants of Cardiovascular Mortality in the Soviet Union," International Journal of Epidemiology 18, suppl 1 (1989): S137-S144. (Pubitemid 19270204)
62. Shkolnikov et al., "Health Crisis in Russia"
63. V. Shkolnikov, F. Mesle, and J. Vallin, "Health Crisis in Russia. II. Changes in Causes of Death: A Comparison with France and England and Wales (1970 to 1993)," Population: English Selection 8 (1996): 155-189
64. F. C. Notzon et al., "Causes of Declining Life Expectancy in Russia," JAMA 279, no. 10 (1998): 793-800 (Pubitemid 28115008)
65. David A. Leon and Vladimir M. Shkolnikov, "Social Stress and the Russian Mortality Crisis," JAMA 279, no. 10 (1998): 790-791. (Pubitemid 28115007)
66. See also Mark G. Field, David M. Kotz, and Gene Bukhman, "Neoliberal Economic Policy, 'State Desertion,' and the Russian Health Crisis" in Dying for Growth: Global Inequality and a the Health of the Poor, ed. Jim Yong Kim et al. (ME Monroe: Common Courage Press, 2000), pp. 155-173.
67. Notzon et al., "Causes," 799.
68. S. C. Tao et al., "CHD and Its Risk Factors in the People's Republic of China," International Journal of Epidemiology, 18, suppl 1 (1989): S159-S163.
69. J. Critchley et al., "Explaining the Increase in Coronary Heart Disease Mortality in Beijing between 1984 and 1999," Circulation 110, no. 10 (2004): 1236-1244, on p. 1236. (Pubitemid 39202339)
70. J. Cheng et al., "The Impact of Demographic and Risk Factor Changes on Coronary Heart Disease Deaths in Beijing, 1999-2010," Bio Med Central Public Health 9 (2009): 30 [11 pages].
71. K. Srinath Reddy, "Foreword," in Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries, eds. Stephen Leeder, Susan Raymond, and Henry Greenberg (New York, NY: Trustees of Columbia University, 2004), on p. vi.
72. World Bank. Investing in Health: World Development Report 1993 (New York, NY: Oxford University Press, 1993), on p. 225.
73. K. Srinath Reddy, "Cardiovascular Disease in Non-Western Countries," New England Journal of Medicine 350, no. 24 (2004): 2438-2440.
74. Colin D. Mathers and Dejan Loncar, "Projections of Global Mortality and Burden of Disease from 2002 to 2030," PLoS Medicine 3, no. 11 (2006): 2011-2030, especially table 3. (Pubitemid 44875937)
75. A. Chockalingam et al. "The World Heart Federation's White Book: Impending Global Pandemic of Cardiovascular Diseases: Challenges and Opportunities for the Prevention and Control of Cardiovascular Diseases in Developing Countries and Economies in Transition," Canadian Journal of Cardiology 16, no. 2 (2000): 227-229, on p. 227.
76. R. Beaglehole et al., for The Lancet NCD Action Group and the NCD Alliance, "Priority Actions for the Non-communicable Disease Crisis," Lancet 377, no. 9775 (2011): 1438-1447
77. General Assembly of the United Nations, "Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases," Draft Resolution (September 16, 2011), http://www.un.org/en/ga/ncdmeeting2011 (accessed October 30, 2011).
78. The concern about possible futures has been amplified by fear that little will be done. Consider, for instance, the debates and modest proposals that emerged from assembly: Sheri Fink and Rebecca Rabinowitz, "The UN's Fight Against NCDs: How Politics, Commerce, and Science Complicated the Fight Against an 'Invisible Epidemic,'" Foreign Affairs (2011), http://www. foreignaffairs.com/articles/68280/sheri-fink-and-rebeccarabinowitz/ the-uns-battle-withncds? page=show (accessed November 9, 2011).
79. H. Dowling, Fighting Infection: Conquests of the Twentieth Century (Cambridge, MA: Harvard University Press, 1977).
80. Abdel R. Omran, "The Epidemiologic Transition: A Theory of the Epidemiology of Population Change," Milbank Memorial Fund Quarterly 49, no. 4 (1971): 509-538
81. George Weisz and Jesse Olszynjo-Gryn, "The Theory of Epidemiologic Transition: The Origins of a Citation Classic," Journal of the History of Medicine and Allied Sciences 65, no. 3 (2010): 287-326.
82. Thomas McKeown. The Role of Medicine: Dream, Mirage, or Nemesis? (London: Nuffield Provincial Hospitals Trust, 1976)
83. James Colgrove, "The McKeown Thesis: A Historical Controversy and Its Enduring Influence," American Journal of Public Health 92, no. 5 (2002): 725-729. (Pubitemid 34441619)
84. Ivan Illich, Medical Nemesis: The Expropriation of Health (New York, NY: Pantheon Books, 1976).
85. see: Abdel R. Omran, "Epidemiologic Transition in the United States: The Health Factor in Population Change," Population Bulletin 32, no. 2 (1977): 1-42
86. S. Wing et al., "Geographic Variation in the Onset of Decline of Ischemic Heart Disease Mortality in the United States," American Journal of Public Health 76, no. 12 (1986): 404-408
87. Cooper et al., "Trends and Disparities," 3139-3140
88. S. Jay Olshansky et al., "Differences In Life Expectancy Due to Race And Educational Differences Are Widening, and Many May Not Catch Up," Health Affairs (Millwood) 31, no. 8 (2012): 1803-1813.
89. J. Frenk et al., "Health Transition in Middle-Income Countries: New Challenges for Health Care," Health Policy Plan 4, no. 1 (1989): 29-39. (Pubitemid 19085715)
90. Kari Kuulasmaa et al., for the WHO MONICA Project, "Estimation of Contribution of Changes in Classic Risk Factors to Trends in Coronary-Event Rates Across the WHO MONICA Project Populations," Lancet 355, no. 9205 (2000): 675-687, on p. 685. (Pubitemid 30107623)
91. R. Bud, Penicillin: Triumph and Tragedy (Oxford, UK: Oxford University Press, 2007)
92. Scott Podolsky, "Pharmacological Restraint: Antibiotic Prescribing and Physician Autonomy," in Prescribed: Writing, Filling, Using, and Abusing Prescriptions in Modern America, ed. J. Greene and E. Watkins, (Baltimore, MD: Johns Hopkins University Press, 2012): 46-65.
93. Thomas R. Frieden et al., "Tuberculosis in New York City-Turning the Tide," New England Journal of Medicine 333, no. 4 (1995): 229-233.
94. See Richard Preston, The Hot Zone (New York, NY: Anchor Books, 1994)
95. Laurie Garrett, The Coming Plague: Newly Emerging Diseases in a World Out of Balance (New York, NY: Penguin, 1995).
96. see Allan M. Brandt, No Magic Bullet: A Social History of Venereal Diseases in the United States Since 1980 (Oxford, UK: Oxford University Press, 1985)
97. Howard Markel, When Germs Travel: Six Major Epidemics That Have Invaded America and the Fears They Have Unleashed (New York, NY: Vintage, 2005).
98. see Andrew Lakoff, "The Generic Biothreat, or, How We Became Unprepared," Cultural Anthropology 23 (2008): 399-428.
99. N. B. King "The Scale Politics of Emerging Diseases," Osiris 19 (2004): 62-76.
100. G. L. Armstrong, L. A. Conn, and R.W. Pinner, "Trends in Infectious Disease Mortality in the United States During the 20th Century," JAMA 281, no. 1 (1999): 61-66, on p. 61. (Pubitemid 29025101)
101. G. Bukhman and A. Kidder, "Cardiovascular Disease and Global Health Equity: Lessons from Tuberculosis Control Then and Now," American Journal of Public Health 98, no. 1 (2008): 44-54. (Pubitemid 351302593)
102. Olshansky et al., "A Potential Decline."
103. S. J. Olshansky et al., "Infectious Diseases-New and Ancient Threats to World Health," Population Bulletin 52, no. 2 (1997): 1-52. He explained: "As health officials and scientists from various disciplines examined the forces responsible for these unexpected developments, they realized that the hope that IPDs [infectious and parasitic diseases] would soon be conquered was premature" (on p. 3).
104. Havlik and Feinleib, Proceedings of the Conference, p. 163.
105. Jones and Greene, "The Contributions of Prevention and Treatment."
106. Adam Hedgecoe and Paul Martin, "The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics," Social Studies of Science 33, no. 3 (2003): 327-364 (Pubitemid 37340838)
107. Richard Tutton, "Promising Pessimism: Reading the Futures to Be Avoided in Biotech, Social Studies of Science 41, no. 3 (2011): 411-429.
108. M. Fortun, "Mediated Speculations in the Genomics Futures Markets," New Genetics and Society 20 (2001): 139-156 (Pubitemid 32783428)
109. Charis Thompson, Making Parents: The Ontological Choreography of Reproductive Technologies (Cambridge, MA: MIT Press, 2005)
110. Kaushik Sunder Rajan, Biocapital: The Constitution of Post-Genomic Life (Durham, NC: Duke University Press, 2006)
111. M. Fortun, Promising Genomics: Iceland and deCODE Genetics in a World of Speculation (Berkeley, CA: University of California Press, 2008)
112. David S. Jones, "The Prospects of Personalized Medicine," in Genetic Explanation: Sense and Nonsense, ed. Sheldon Krimsky (Cambridge, MA: Harvard University Press, 2013).
113. King, "Scale Politics"
114. Lakoff, "The Generic Biothreat."
115. see Anna B. Gilmore, Emily Savell, and Jeff Collin, "Public Health, Corporations, and the New Responsibility Deal: Promoting Partnerships with Vectors of Disease," Journal of Public Health (Oxford) 33, no. 1 (2011): 2-4
116. Kelly D. Brownell, "Thinking Forward: The Quicksand of Appeasing the Food Industry," PLoS Medicine 9, no. 7 (2012): e1001254
117. Simon Capewell, e-mail to authors, October 15, 2012.